红细胞生成素

hónɡ xì bāo shēnɡ chénɡ sù
  • Erythropoietin;epo;hematopoietin
红细胞生成素红细胞生成素
  1. 红细胞生成素疗效的影响因素分析及用药指导

    Analysis on Influencial Factors and Medication Guide of the Effect of Hematopoietin

  2. 肌肉注射裸DNA后人红细胞生成素在小鼠体内的表达

    Expression of human erythropoietin in mice after intramuscular injection of naked DNA

  3. 治疗B组8只,脊髓损伤,联合应用重组人红细胞生成素和β-七叶皂甙钠。

    Eight rats in medication B group were treated with rhEPO and β - aeacine sodium .

  4. 中国人红细胞生成素cDNA克隆与高效表达

    CDNA cloning and high expression of Chinese erythropoietin

  5. 自制的人尿红细胞生成素活力测定Ⅰ、多血小鼠红细胞~(59)Fe掺入法

    Bioassay of erythropoietin activity in human urine ~ ( 59 ) fe incorporation rate in red cells of polycythemic mice

  6. 噻唑蓝法(MTT)检测红细胞生成素(Epo)对脐血细胞增殖的影响;

    MNC proliferation in response to erythropoietin ( Epo ) was measured by MTT ;

  7. 红细胞生成素对面神经损伤后运动神经元存活及iNOS表达的作用

    Effect of Erythropoietin on Survival of Facial Motoneurons and Expression of iNOS after Axotomy

  8. 红细胞生成素(EPO)在临床和基础研究中应用广泛。

    Erythropoietin ( EPO ) is widely used in clinical and basic studies .

  9. 方法红细胞生成素测定采用酶联法。酶联免疫反应(ELISA)法测定各细胞培养液中FN的浓度;

    Methods EPO was determined with ELISA . The level of FN in medium was detected by using ELISA method .

  10. 重组人红细胞生成素对癫痫持续状态大鼠海马神经元磷酸化Akt表达的影响

    Effect of rHuEPO on the expression of p-Akt in hippocampus of statural epilepticus rats

  11. 含SV(40)串联启动子红细胞生成素逆转录病毒表达载体的构建

    Cloning of Human Erythropoietin Genome with SV_ ( 40 ) Series Promoter in A Retroviral Vector

  12. 目的:评价重组红细胞生成素(rhEPO)对透析患者免疫功能的影响。

    To evaluate the effect and related mechanism of rh EPO on cellular immune functional parameters in hemodialysis patients .

  13. 7例尿毒症贫血患者在自发急性缺氧状态下,其血清红细胞生成素(EPO)浓度显著提高(平均7倍),且与PO2呈负相关。

    Change of serum erythropoietin ( EPO ) level was determined in seven uremic patients under spontaneous acute anoxia .

  14. 间接抗体夹心酶联免疫吸附法测定人红细胞生成素(EPO)体外活性

    Determination of Erythropoietin ( EPO ) potency in vitro with indirection antibodies sandwich in enzyme linked immunosorbent method

  15. 方法用重组人红细胞生成素二聚体表达载体转染COS-7细胞,通过dotblot进行检定。

    Methods Transiently transfect COS-7 cells with expression vector pBT-2s of recombinant human dimeric erythropoietin and identify by dot blot .

  16. 目的:了解慢性肾功能衰竭继发性甲状旁腺功能亢进症(简称慢性肾衰继发性甲旁亢)患者对红细胞生成素(EPO)疗效的影响。

    Objective : To explore the effect of erythropoietin ( EPO ) on patients of chronic renal failure with hyperparathyroidism .

  17. 目的研究电脉冲介导的质粒红细胞生成素(EPO)基因肌肉转移效率以及对肾性贫血的治疗作用。

    Objective To investigate the effects of erythropoietin ( EPO ) gene transfer into skeleton muscle mediated by electroporation on renal anemia .

  18. 国际奥委会药物委员会了一项测试来检测违禁使用合成激素红细胞生成素(简称EPO)的情况。

    The IOC Medical Commission has approved a test to detect the use of the banned synthetic hormone erythropoietin , or EPO .

  19. 肾性贫血主要是由于肾脏产生红细胞生成素(EPO)不足而引起,这类贫血主要靠补充外源性EPO进行治疗。

    Renal anemia is mostly caused by insufficient EPO produced by kidney , which mainly required to be treated with external EPO .

  20. 重组人红细胞生成素改善UUO大鼠肾脏纤维化的研究

    Protective Effect of Recombinant Human Erythropoietin in Renal Tubulointerstitial Fibrosis with UUO in Rat

  21. 重组人红细胞生成素(RecombinantHumanErythropoietin,rhEPO)是一种含唾液酸的酸性糖蛋白,可以促进造血祖细胞的增殖与分化。

    Recombinant human erythropoietin ( rhEPO ), as a acid glycoprotein , had been regarded as a body fluid factor concerning promoting proliferation and differentiation of the blood ancestral cell .

  22. 方法:采用浸泡释放法,用HPLC法测定释放液中红细胞生成素的量,计算不同时间点的累积释放百分率。

    Methods : The minipellets were dipped in PBS release medium and HPLC method was used to determine the EPO content of the release medium and to calculate the cumulative release rate of EPO .

  23. 介绍一种简便、有效的红细胞生成素(EPO)体内生物学活性检测方法&网织红细胞法(简称网织红法)。

    A simple and effective method ( reticulacyte counting method ) use for the detection of the biological activity in vivo of EPO was reported .

  24. 目的:探讨透析病人重组人红细胞生成素(rHuEPO)的维持用量。

    AIM : To research the maintenance dose of recombinant human erythropoietin ( rHuEPO ) in dialysis patients .

  25. 红细胞生成素对大鼠心肌梗死后间质重塑及MMPs、TIMP-4表达的影响

    Effects of erythropoietin on matrix remodeling and the expressions of MMPs and TIMP-4 after myocardial infarction in rats

  26. 目的:对不同剂量的重组人红细胞生成素(rhEPO)治疗癌症贫血的临床疗效进行评价。

    OBJECTIVE : To study the clinical effect of recombinant human erythropoietin ( rhEPO ) at different doses on cancer-associated anemia .

  27. 目的:研究幼仓鼠肾(BHK)细胞表达红细胞生成素(EPO)在猕猴体内的药动学。

    OBJECTIVE : To study the pharmacokinetics of recombinant human erythropoietin ( rEPO ) produced by baby hamster kidney cells ( BHK ) .

  28. 目的了解大剂量重组人红细胞生成素(rHuEPO)改善化疗患者相关性贫血并提高其生活质量的情况。

    OBJECTIVE To investigate the effect of high dose of recombinative human erythropoietin ( rHuEPO ) on the treatment of chemotherapy-induced anemia .

  29. 红细胞生成素(EPO)通过减少骨髓红系祖细胞凋亡,促进红系祖细胞增殖,对于正常红系集落(CFU-E)的形成至关重要。

    Erythropoietin inhibited apoptosis and improved the proliferation of erythroid progenitors , so it was essential for the formation of colony forming unit-erythroid ( CFU-E ) .

  30. 目的:观察重组红细胞生成素(rHuEPO)对慢性肾功能衰竭(CRF)大鼠血清瘦素、神经肽Y水平的影响。

    Aim : To investigate the effect of recombinant human erythropoietin ( rHuEPO ) on serum leptin and plasma neuropeptide Y in chronic renal failure ( CRF ) rats .